Heterophilic antibodies causing falsely high serum calcitonin values

Peter D. Papapetrou1, Antonis Polymeris1, Helen Karga1, G Vaiopoulos2
1Second Division of Endocrinology, Alexandra Hospital, Greece
2First Department of Internal Medicine, University of Athens School of Medicine, Laikon Hospital, Athens, Greece

Tóm tắt

Từ khóa


Tài liệu tham khảo

Becker KL, Muller B, Nylen ES, et al. Calcitonin gene family of peptides. In: Becker KL ed. Principles and practice of endocrinology and metabolism. 3rd ed. Philadelphia: Lippincot Williams and Wilkins. 2001, 520–34.

Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem 1999, 45: 942–6.

Levinson SS, Miller JJ. Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays. Clin Chim Acta 2002, 325: 1–15.

Preissner CM, O’Kane DJ, Singh RJ, Morris JC, Grebe SKG. Phantoms in the assay tube: heterophile antibody interferences in thyroglobulin assays. J Clin Endicrinol Metab 2003, 88: 3069–74.

Tommasi M, Brocchi A, Cappellini A, Raspanti S, Mannelli M. False serum calcitonin high levels using a non-competitive two-site IRMA. J Endocrinol Invest 2001, 24: 356–60.

Pantazi H, Papapetrou PD. Calcitonin levels are similar in goitrous euthyroid patients with or without thyroid antibodies, as well as in hypothyroid patients. Eur J Endocrinol 1998, 138: 530–5.

d’Herbonez M, Lerlerc L, Vantyghem MC, Fourrier F, Proye C, Wemeau JL. Clinical evaluation of a new sensitive calcitonin assay: study of specificity. Clin Chim Acta 2001, 311: 149–55.

Carey DE, Jones KL, Parthemore JG, Deftos LJ. Calcitonin secretion in congenital nongoitrous cretinism. J Clin Invest 1980, 65: 892–5.

Ward G, McKinon L, Badrick T, Hickman PE. Heterophilic antibodies remain a problem for the immunoassay laboratory. Am J Clin Pathol 1997, 108: 417–21.

Horvit PK, Gagel RF. The goitrous patient with an elevated serum calcitonin what to do? J Clin Endocrinol Metab 1997, 82: 335–7.

Niccoli P, Wion-Barbot N, Caron P, et al. Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. J Clin Endocrinol Metab 1997, 82: 338–41.

Elisei R, Bottici V, Luchetti F, et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 2004, 89: 163–8.

Hodak SP, Burman KD. The calcitonin conundrum — is it time for routine measurement of serum calcitonin in patients with thyroid nodules? J Clin Endocrinol Metab 2004, 89: 511–4.

Tighe H, Carson DA. Rheumatoid factors. In: Lelley WN, Harris ED, Ruddy S, Sledge CB eds. Texbook of Rheumatology. Philadelphia: WB Saunders. 1997, 241–9.

Cohen R, Campos JM, Salaun C, et al. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. J Clin Endocrinol Metab 2000, 85: 919–22.

Yokoi K, Imai T, Shibata A, et al. Mild persistent hypercalcitoninemia after total thyroidectomy in patients with papillary thyroid carcinoma. Endocr J 2003, 50: 453–8.